Prostate Cancer Reports
54

Volume 5 Number 12
December 2017


Home > Prostate Cancer Reports > Volume 5, Year 2017 > Number 12, December



CONTENTS



DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT



DIAGNOSIS



Byrne K, Eade T, Kneebone A, Guo L, Hsiao E, Schembri G, Kwong C, Hunter J, Emmett L, Hruby G.
Delineating sites of failure following post-prostatectomy radiation treatment using 68Ga-PSMA-PET.
Radiother Oncol. 2017 Nov 10. pii: S0167-8140(17)32662-2. doi: 10.1016/j.radonc.2017.10.022. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Evans JD, Jethwa KR, Ost P, Williams S, Kwon ED, Lowe VJ, Davis BJ.
Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent disease.
Pract Radiat Oncol. 2017 Jul 20. pii: S1879-8500(17)30206-0. doi: 10.1016/j.prro.2017.07.011. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Gansler T, Fedewa S, Qi R, Lin CC, Jemal A, Moul JW.
Most Gleason 8 Biopsies are Downgraded on Prostatectomy: Does 4+4=7?
J Urol. 2017 Oct 11. pii: S0022-5347(17)77718-X. doi: 10.1016/j.juro.2017.10.014. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Grubmüller B, Baltzer P, D'Andrea D, Korn S, Haug AR, Hacker M, Grubmüller KH, Goldner GM, Wadsak W, Pfaff S, Babich J, Seitz C, Fajkovic H, Susani M, Mazal P, Kramer G, Shariat SF, Hartenbach M.
68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy - diagnostic performance and impact on therapeutic decision-making.
Eur J Nucl Med Mol Imaging. 2017 Oct 26. doi: 10.1007/s00259-017-3858-2. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Hruby G, Eade T, Kneebone A, Emmett L, Guo L, Ho B, Hsiao E, Schembri G, Hunter J, Kwong C.
Delineating biochemical failure with 68Ga-PSMA-PET following definitive external beam radiation treatment for prostate cancer.
Radiother Oncol. 2017 Jan;122(1):99-102. doi: 10.1016/j.radonc.2016.11.023. Epub 2016 Dec 28.
Source | Abstract | Full text | Similar articles




Kranzbühler B, Nagel H, Becker AS, Müller J, Huellner M, Stolzmann P, Muehlematter U, Guckenberger M, Kaufmann PA, Eberl
Clinical performance of 68Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy.
Eur J Nucl Med Mol Imaging. 2017 Oct 14. doi: 10.1007/s00259-017-3850-x. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Loeb S, Dani H.
Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.
Urol Clin North Am. 2017 Nov;44(4):517-524. doi: 10.1016/j.ucl.2017.07.001.
Source | Abstract | Full text | Similar articles




Minamimoto R, Sonni I, Hancock S, Vasanawala S, Loening A, Gambhir SS, Iagaru A.
Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Conventional Imaging.
J Nucl Med. 2017 Oct 30. pii: jnumed.117.197624. doi: 10.2967/jnumed.117.197624. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Sandgren K, Westerlinck P, Jonsson JH, Blomqvist L, Thellenberg Karlsson C, Nyholm T, Dirix P.
Imaging for the Detection of Locoregional Recurrences in Biochemical Progression After Radical Prostatectomy-A Systematic Review.
Eur Urol Focus. 2017 Nov 10. pii: S2405-4569(17)30257-2. doi: 10.1016/j.euf.2017.11.001. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



EPIDEMIOLOGY, RISK FACTORS, PREVENTION



Stanaland M, Jiroutek MR, Holland MA.
Study of the Association Between Serum Vitamin D Levels and Prostate Cancer.
Mil Med. 2017 May;182(5):e1769-e1774. doi: 10.7205/MILMED-D-16-00331.
Source | Abstract | Full text | Similar articles




Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM.
Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™).
Prostate. 2017 Nov 6. doi: 10.1002/pros.23441. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



FOLLOW-UP, QUALITY OF LIFE



Fode M, Østergren PB, Jensen CFS, Jakobsen H, Sønksen J.
Treatment effects of phosphodiesterase-5 inhibitors may improve with time following nerve-sparing radical prostatectomy.
Scand J Urol. 2017 Oct 23:1-3. doi: 10.1080/21681805.2017.1387603. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



INTEGRATIVE MEDICINE



Dickerman BA, Ahearn TU, Giovannucci E, Stampfer MJ, Nguyen PL, Mucci LA, Wilson KM.
Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer.
Int J Cancer. 2017 Sep 1;141(5):933-944. doi: 10.1002/ijc.30803. Epub 2017 Jun 8.
Source | Abstract | Full text | Similar articles




Mantzorou M, Koutelidakis A, Theocharis S, Giaginis C.
Clinical Value of Nutritional Status in Cancer: What is its Impact and how it Affects Disease Progression and Prognosis?
Nutr Cancer. 2017 Oct 30:1-26. doi: 10.1080/01635581.2017.1367947. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Reger MK, Zollinger TW, Liu Z, Jones JF, Zhang J.
Dietary intake of isoflavones and coumestrol and the risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Int J Cancer. 2017 Nov 8. doi: 10.1002/ijc.31095. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Taneja SS.
Re: Weight Change, Obesity and Risk of Prostate Cancer Progression among Men with Clinically Localized Prostate Cancer.
J Urol. 2017 Nov;198(5):982. doi: 10.1016/j.juro.2017.08.036. Epub 2017 Aug 9.
Source | Abstract | Full text | Similar articles



OVERALL MANAGEMENT



Cassinello J, Arranz JÁ, Piulats JM, Sánchez A, Pérez-Valderrama B, Mellado B, Climent MÁ, Olmos D, Carles J, Lázaro M.
SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017).
Clin Transl Oncol. 2017 Nov 13. doi: 10.1007/s12094-017-1783-2. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Zaman MU, Fatima N, Zaman A, Sajid M, Zaman U, Zaman S.
Diagnostic Challenges in Prostate Cancer and 68Ga-PSMA PET Imaging: A Game Changer?
Asian Pac J Cancer Prev. 2017 Oct 26;18(10):2625-2628.
Source | Abstract | Full text | Similar articles



PROGNOSIS



Bjurlin MA, Taneja SS.
Prediagnostic Risk Assessment with Prostate MRI and MRI-Targeted Biopsy.
Urol Clin North Am. 2017 Nov;44(4):535-546. doi: 10.1016/j.ucl.2017.07.012.
Source | Abstract | Full text | Similar articles




Offermann A, Hohensteiner S, Kuempers C, Ribbat-Idel J, Schneider F, Becker F, Hupe MC, Duensing S, Merseburger AS, Kirfel J, Reischl M, Lubczyk V, Kuefer R, Perner S.
Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups.
Front Med (Lausanne). 2017 Sep 29;4:157. doi: 10.3389/fmed.2017.00157. eCollection 2017.
Source | Abstract | Full text | Similar articles



TREATMENT



Chen L, Li Q, Wang Y, Zhang Y, Ma X.
Comparison on efficacy of radical prostatectomy versus external beam radiotherapy for the treatment of localized prostate cancer.
Oncotarget. 2017 Aug 9;8(45):79854-79863. doi: 10.18632/oncotarget.20078. eCollection 2017 Oct 3.
Source | Abstract | Full text | Similar articles




Herlemann A, Washington SL 3rd, Eapen RS, Cooperberg MR.
Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier.
Urol Clin North Am. 2017 Nov;44(4):547-555. doi: 10.1016/j.ucl.2017.07.003.
Source | Abstract | Full text | Similar articles




Hoffman RM, Lo M, Clark JA, Albertsen PC, Barry MJ, Goodman M, Penson DF, Stanford JL, Stroup AM, Hamilton AS.
Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study.
J Clin Oncol. 2017 Jul 10;35(20):2306-2314. doi: 10.1200/JCO.2016.70.6317. Epub 2017 May 11.
Source | Abstract | Full text | Similar articles




Rodriguez JF, Liauw SL, Eggener SE.
Managing Cancer Relapse After Radical Prostatectomy: Adjuvant Versus Salvage Radiation Therapy.
Urol Clin North Am. 2017 Nov;44(4):597-609. doi: 10.1016/j.ucl.2017.07.011.
Source | Abstract | Full text | Similar articles




Serrell EC, Pitts D, Hayn M, Beaule L, Hansen MH, Sammon JD.
Review of the comparative effectiveness of radical prostatectomy, radiation therapy, or expectant management of localized prostate cancer in registry data.
Urol Oncol. 2017 Nov 6. pii: S1078-1439(17)30530-6. doi: 10.1016/j.urolonc.2017.10.003. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Syed YA, Patel-Yadav AK, Rivers C, Singh AK.
Stereotactic radiotherapy for prostate cancer: A review and future directions.
World J Clin Oncol. 2017 Oct 10;8(5):389-397. doi: 10.5306/wjco.v8.i5.389.
Source | Abstract | Full text | Similar articles




Taneja SS.
Re: Treatment Decision Regret among Long-Term Survivors of Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study.
J Urol. 2017 Nov;198(5):980-983. doi: 10.1016/j.juro.2017.08.034. Epub 2017 Aug 9.
Source | Abstract | Full text | Similar articles




Tendulkar R.
Point: Early Salvage vs Adjuvant Radiotherapy for High-Risk Prostate Cancer.
Oncology (Williston Park). 2017 Oct 15;31(10):750-2.
Source | Abstract | Full text | Similar articles




Tourinho-Barbosa R, Srougi V, Nunes-Silva I, Baghdadi M, Rembeyo G, Eiffel SS, Barret E, Rozet F, Galiano M, Cathelineau X, Sanchez-Salas R.
Biochemical recurrence after radical prostatectomy: what does it mean?
Int Braz J Urol. 2017 Oct 17;43. doi: 10.1590/S1677-5538.IBJU.2016.0656. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Wu WJ, Potters L.
Counterpoint: Early Salvage vs Adjuvant Radiotherapy for High-Risk Prostate Cancer.
Oncology (Williston Park). 2017 Oct 15;31(10):750, 752-4.
Source | Abstract | Full text | Similar articles